Mark Umbarger

Mark Umbarger is an experienced leader in the biotechnology sector, currently serving as Head of Digital and Vice President at Sail Biomedicines since November 2023, and previously as VP and Head of Discovery at Senda Biosciences. Umbarger held several senior roles at Kintai Therapeutics, including Senior Director of Research Technology, where leadership of a multidisciplinary computational sciences team was a key focus. Prior positions at Good Start Genetics encompassed various roles leading research and development, notably overseeing advancements in next-generation DNA sequencing technologies. Umbarger began an academic career with a Ph.D. in Genetics from Harvard University, following comprehensive undergraduate studies in Chemistry and Molecular Biology at Wesleyan University, as well as postdoctoral work at Harvard Medical School.